149 related articles for article (PubMed ID: 37349251)
21. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
[TBL] [Abstract][Full Text] [Related]
22. Severe Jaundice Increases Early Severe Morbidity and Decreases Long-Term Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma.
Sauvanet A; Boher JM; Paye F; Bachellier P; Sa Cuhna A; Le Treut YP; Adham M; Mabrut JY; Chiche L; Delpero JR;
J Am Coll Surg; 2015 Aug; 221(2):380-9. PubMed ID: 26206638
[TBL] [Abstract][Full Text] [Related]
23. The differential effects of sarcopenia and cachexia on overall survival for pancreatic ductal adenocarcinoma patients following pancreatectomy: A retrospective study based on a large population.
Shen XD; Wang X; Zheng ZJ; Chen YH; Tan CL; Liu XB; Ke NW
Cancer Med; 2023 May; 12(9):10438-10448. PubMed ID: 36938648
[TBL] [Abstract][Full Text] [Related]
24. Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis.
van Erning FN; Mackay TM; van der Geest LGM; Groot Koerkamp B; van Laarhoven HWM; Bonsing BA; Wilmink JW; van Santvoort HC; de Vos-Geelen J; van Eijck CHJ; Busch OR; Lemmens VE; Besselink MG;
Acta Oncol; 2018 Dec; 57(12):1655-1662. PubMed ID: 30264642
[TBL] [Abstract][Full Text] [Related]
25. Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: A multi-center retrospective study.
Matsumoto I; Murakami Y; Shinzeki M; Asari S; Goto T; Tani M; Motoi F; Uemura K; Sho M; Satoi S; Honda G; Yamaue H; Unno M; Akahori T; Kwon AH; Kurata M; Ajiki T; Fukumoto T; Ku Y
Pancreatology; 2015; 15(6):674-80. PubMed ID: 26467797
[TBL] [Abstract][Full Text] [Related]
26. Indications for resection and perioperative outcomes of surgery for pancreatic neuroendocrine neoplasms in Germany: an analysis of the prospective DGAV StuDoQ|Pancreas registry.
Mintziras I; Keck T; Werner J; Fichtner-Feigl S; Wittel U; Senninger N; Vowinkel T; Köninger J; Anthuber M; Geißler B; Bartsch DK;
Surg Today; 2019 Dec; 49(12):1013-1021. PubMed ID: 31240463
[TBL] [Abstract][Full Text] [Related]
27. Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma.
Malleo G; Maggino L; Nobile S; Casciani F; Cacciatori N; Paiella S; Luchini C; Rusev B; Capelli P; Marchegiani G; Bassi C; Salvia R
Eur J Surg Oncol; 2020 Sep; 46(9):1734-1741. PubMed ID: 32327367
[TBL] [Abstract][Full Text] [Related]
28. Association of Long-Term, New-Onset, and Postsurgical Diabetes With Survival in Patients With Resectable Pancreatic Cancer: A Retrospective Cohort Study.
Kanbour S; Yenokyan G; Abusamaan M; Laheru D; Alam A; El Asmar ML; Virk Z; Hardenbergh D; Mathioudakis N
Pancreas; 2023 Jul; 52(6):e309-e314. PubMed ID: 37890159
[TBL] [Abstract][Full Text] [Related]
29. Self-expanding metal stents (SEMS) for preoperative biliary decompression in patients with resectable and borderline-resectable pancreatic cancer: outcomes in 241 patients.
Siddiqui AA; Mehendiratta V; Loren D; Kowalski T; Fang J; Hilden K; Adler DG
Dig Dis Sci; 2013 Jun; 58(6):1744-50. PubMed ID: 23179157
[TBL] [Abstract][Full Text] [Related]
30. Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma.
Malleo G; Mazzarella F; Malpaga A; Marchegiani G; Salvia R; Bassi C; Butturini G
Surgery; 2013 May; 153(5):641-50. PubMed ID: 23276391
[TBL] [Abstract][Full Text] [Related]
31. Medically managed hypercholesterolemia and insulin-dependent diabetes mellitus preoperatively predicts poor survival after surgery for pancreatic cancer.
Chagpar RB; Martin RC; Ahmad SA; Kim HJ; Rupp C; Weber S; Ebelhar A; Gilbert J; Brinkman A; Winslow E; Cho CS; Kooby D; Chu CK; Staley CA; McMasters KM; Scoggins CR
J Gastrointest Surg; 2011 Apr; 15(4):551-7. PubMed ID: 21327533
[TBL] [Abstract][Full Text] [Related]
32. Preoperative Platelet-to-Albumin Ratio Predicts Prognosis of Patients with Pancreatic Ductal Adenocarcinoma After Pancreatic Resection.
Shirai Y; Shiba H; Haruki K; Horiuchi T; Saito N; Fujiwara Y; Sakamoto T; Uwagawa T; Yanaga K
Anticancer Res; 2017 Feb; 37(2):787-793. PubMed ID: 28179331
[TBL] [Abstract][Full Text] [Related]
33. Prediction of residual tumor and overall survival after first-line surgery in patients with pancreatic ductal adenocarcinoma using preoperative magnetic resonance imaging findings.
Bae JS; Kim JH; Kang HJ; Han JK
Acta Radiol; 2022 Apr; 63(4):435-446. PubMed ID: 33682455
[TBL] [Abstract][Full Text] [Related]
34. Clinical presentation and prognosis of adenosquamous carcinoma of the pancreas - Matched-pair analysis with pancreatic ductal adenocarcinoma.
Kaiser J; Hinz U; Mayer P; Hank T; Niesen W; Hackert T; Gaida MM; Büchler MW; Strobel O
Eur J Surg Oncol; 2021 Jul; 47(7):1734-1741. PubMed ID: 33622577
[TBL] [Abstract][Full Text] [Related]
35. Distal pancreatectomy for resectable adenocarcinoma of the body and tail of the pancreas.
Christein JD; Kendrick ML; Iqbal CW; Nagorney DM; Farnell MB
J Gastrointest Surg; 2005; 9(7):922-7. PubMed ID: 16137585
[TBL] [Abstract][Full Text] [Related]
36. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
[TBL] [Abstract][Full Text] [Related]
37. [Indications for Surgery in Pancreatic Ductal Adenocarcinoma - Consensus Recommendations by the German Society for General and Visceral Surgery].
Belyaev O; Bösch F; Brunner M; Müller-Debus CF; Radulova-Mauersberger O; Wellner UF; Grützmann R; Keck T; Werner J; Witzigmann H; Uhl W
Zentralbl Chir; 2020 Aug; 145(4):354-364. PubMed ID: 32615624
[TBL] [Abstract][Full Text] [Related]
38. Second pancreatectomy for recurrent pancreatic ductal adenocarcinoma in the remnant pancreas: A pooled analysis.
Zhou Y; Song A; Wu L; Si X; Li Y
Pancreatology; 2016; 16(6):1124-1128. PubMed ID: 27717684
[TBL] [Abstract][Full Text] [Related]
39. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
Kim NH; Kim HJ
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic delay does not influence survival of pancreatic cancer patients.
Stornello C; Archibugi L; Stigliano S; Vanella G; Graglia B; Capalbo C; Nigri G; Capurso G
United European Gastroenterol J; 2020 Feb; 8(1):81-90. PubMed ID: 32213057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
